Cargando…
Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study
Objective: Conventional immunosuppressive and advanced targeted therapies, including biological medications and small molecules, are a mainstay in the treatment of immune-mediated inflammatory diseases (IMID). However, the COVID-19 pandemic caused concerns over these drugs’ safety regarding the risk...
Autores principales: | Kutschera, Maximilian, Ritschl, Valentin, Reichardt, Berthold, Stamm, Tanja, Kiener, Hans, Maier, Harald, Reinisch, Walter, Benka, Bernhard, Novacek, Gottfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503597/ https://www.ncbi.nlm.nih.gov/pubmed/36142955 http://dx.doi.org/10.3390/jcm11185308 |
Ejemplares similares
-
Tofacitinib in the treatment of ulcerative colitis: A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)
por: Kutschera, Maximilian, et al.
Publicado: (2022) -
COVID-19 Pandemic and Its Impact on Pediatric Dentistry in Austria: Knowledge, Perception and Attitude Among Pediatric Dentists in a Cross-Sectional Survey
por: Bekes, Katrin, et al.
Publicado: (2021) -
The COVID-19 Pandemic and Its Impact on Knowledge, Perception and Attitudes of Dentistry Students in Austria: A Cross-Sectional Survey
por: Boukhobza, Sarra, et al.
Publicado: (2021) -
Management of suspected and known eosinophilic esophagitis—a nationwide survey in Austria
por: Schreiner, Philipp, et al.
Publicado: (2023) -
A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease
por: Reinisch, Walter, et al.
Publicado: (2015)